 OSLO, Norway--BUSINESS WIRE--- ULTI 4Q20--Ultimovacs ASA Ultimovacs, ticker ULTI, a pharmaceutical company developing novel immunotherapies against cancer, announces its fourth quarter 2021 results today. A presentation by the companys management team will take place today on a webcast at 09:00 CET. The presentation can be followed as a live webcast, which will also be available on our corporate website. Highlights for the fourth quarter of 2020: Ultimovacs provided details about the DOVACC trial in 